Log in to save to my catalogue

Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner

Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3387563

Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner

About this item

Full title

Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2011-08, Vol.17 (8), p.961-967

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Notch, a molecule widely known for its role in development and cancer, regulates hepatic glucose metabolism by offsetting excessive glucose production. Given that a series of Notch antagonists are in clinical trials against cancer, they could also be useful against type 2 diabetes.
Transcription factor FoxO1 promotes hepatic glucose production....

Alternative Titles

Full title

Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3387563

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3387563

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.2378

How to access this item